| Estimation of Tau and Phosphorylated Tau181 in Serum of Alzheimer’s Disease and Mild Cognitive Impairment Patients S Shekhar, R Kumar, N Rai, V Kumar, K Singh, AD Upadhyay, M Tripathi, ... PLoS One 11 (7), e0159099, 2016 | 56 | 2016 |
| Serum 5-LOX: a progressive protein marker for breast cancer and new approach for therapeutic target R Kumar, AK Singh, M Kumar, S Shekhar, N Rai, P Kaur, R Parshad, ... Carcinogenesis 37 (9), 912-917, 2016 | 23 | 2016 |
| Relative alterations in blood-based levels of sestrin in Alzheimer’s disease and mild cognitive impairment patients N Rai, R Kumar, GR Desai, G Venugopalan, S Shekhar, P Chatterjee, ... Journal of Alzheimer's Disease 54 (3), 1147-1155, 2016 | 17 | 2016 |
| Diagnostic Significance of p38 Isoforms (p38α, p38β, p38γ, p38δ) in Head and Neck Squamous Cell Carcinoma: Comparative serum level evaluation and design of novel peptide … V Sahu, L Nigam, V Agnihotri, A Gupta, S Shekhar, N Subbarao, ... Cancer Research and Treatment: Official Journal of Korean Cancer Association …, 2019 | 15 | 2019 |
| Neuroprotection by ethanolic extract of Syzygium aromaticum in Alzheimer's disease like pathology via maintaining oxidative balance through SIRT1 pathway S Shekhar, Y Yadav, AP Singh, R Pradhan, GR Desai, AB Dey, S Dey Experimental gerontology 110, 277-283, 2018 | 15 | 2018 |
| 5-LOX in Alzheimer’s disease: potential serum marker and in vitro evidences for rescue of neurotoxicity by its inhibitor YWCS S Shekhar, SK Yadav, N Rai, R Kumar, Y Yadav, M Tripathi, AB Dey, ... Molecular Neurobiology 55 (4), 2754-2762, 2018 | 12 | 2018 |
| Longevity and healthy ageing genes FOXO3A and SIRT3: serum protein marker and new road map to burst oxidative stress by Withania somnifera R Pradhan, R Kumar, S Shekhar, N Rai, A Ambashtha, J Banerjee, ... Experimental gerontology 95, 9-15, 2017 | 10 | 2017 |
| Synthesis and biological evaluation of novel peptide BF2 as an antibacterial agent against clinical isolates of vancomycin-resistant enterococci K Singh, S Kumar, S Shekhar, B Dhawan, S Dey Journal of Medicinal Chemistry 57 (21), 8880-8885, 2014 | 10 | 2014 |
| DS6: anticandidal, antibiofilm peptide against Candida tropicalis and exhibit synergy with commercial drug K Singh, S Shekhar, Y Yadav, I Xess, S Dey Journal of Peptide Science 23 (3), 228-235, 2017 | 9 | 2017 |
| Serum FOXO3A: A ray of hope for early diagnosis of Alzheimer’s disease R Pradhan, SK Yadav, NN Prem, V Bhagel, M Pathak, S Shekhar, ... Mechanisms of Ageing and Development 190, 111290, 2020 | 5 | 2020 |
| Induction of p73, Δ133p53, Δ160p53, pAKT lead to neuroprotection via DNA repair by 5-LOX inhibition S Shekhar, S Dey Molecular Biology Reports 47 (1), 269-274, 2020 | 4 | 2020 |
| Design and in vitro analysis of SIRT2 inhibitor targeting Parkinson’s disease AP Singh, L Nigam, Y Yadav, S Shekhar, N Subbarao, S Dey Molecular Diversity 25 (4), 2261-2270, 2021 | 1 | 2021 |
| Impact of physical activity on mitochondrial enzymes, muscle stem cell and anti-oxidant protein Sestrins in Sarcopenic mice M Anwar, SR Mallick, D Paliwal, S Shekhar, SK Panda, S Dey, AB Dey Experimental Gerontology 150, 111358, 2021 | 1 | 2021 |
| Circulatory GSK-3β: Blood-Based Biomarker and Therapeutic Target for Alzheimer’s Disease S Kumari, A Singh, AK Singh, Y Yadav, S Bajpai, P Kumar, AD Upadhyay, ... Journal of Alzheimer's Disease 85 (1), 249-260, 2022 | | 2022 |
| Exploring the Serum Level of RE1 Silencing Transcription Factor in Alzheimer’s Disease S Shekhar, M Tripathi, AB Dey, S Dey Annals of the National Academy of Medical Sciences (India), 2021 | | 2021 |
| FOXO3a: Potential Blood Based Protein Marker for Alzheimer's Disease R Pradhan, SK Yadav, S Shekhar, V Bhagel, M Pathak, S Gaikwad, ... Available at SSRN 3529447, 2020 | | 2020 |
| Molecular Marker and Therapeutic Regimen for Neurodegenerative Diseases S Dey, N Rai, S Shekhar, AP Singh, V Agnihotri Models, Molecules and Mechanisms in Biogerontology, 13-41, 2019 | | 2019 |
| TAU, P-TAU 181, AND γ-SECRETASE LEVEL: BLOOD-BASED MARKER FOR AD AND MCI S Shekhar, N Rai, SK Yadav, A Dey, S Dey Innovation in Aging 1 (Suppl 1), 1152, 2017 | | 2017 |
| [P3–244]: SESTRIN LEVELS IN PATIENTS DIAGNOSED WITH MILD COGNITIVE IMPAIRMENT AND ALZHEIMER's DISEASE: A POTENTIAL MARKER N Rai, AP Singh, S Shekhar, Y Yadav, AB Dey, S Dey Alzheimer's & Dementia 13 (7S_Part_21), P1033-P1034, 2017 | | 2017 |
| Evaluation of serum sestrin protein in Parkinson's disease: a plausible diagnostic marker S Dey, N Rai, A Singh, S Shekhar, A Dey MOVEMENT DISORDERS 32, 2017 | | 2017 |
Manoj KumarAll India institute of Medical sciences, New DelhiVerified email at aiims.ac.in
